lacidipine

Known as: diethyl 2,6-dimethyl-4-(2-((E)-2-((2-methylpropan-2-yl)oxycarbonyl)ethenyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate, lacidipine [Chemical/Ingredient] 
 

Topic mentions per year

Topic mentions per year

1989-2017
0102019892017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND In high-cardiovascular-risk treated hypertensive patients, the incidence of cardiovascular events has been reported to… (More)
  • table 1
  • table 2
  • table 3
  • table 1
  • table 2
Is this relevant?
2010
2010
The aim of this study was to develop and optimize SNEDDS formulations containing surfactants reported to be bioenhancers for… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Most cardiovascular events associated with hypertension are complications of atherosclerosis. Some antihypertensive… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Baseline data from the European Lacidipine Study on Atherosclerosis (ELSA) have shown that carotid intima-media… (More)
Is this relevant?
2000
2000
The aim of our study was to assess the effects of lacidipine, a long-acting calcium antagonist, on 24-hour average blood pressure… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2000
2000
BACKGROUND AND OBJECTIVE The European Lacidipine Study of Atherosclerosis (ELSA) is a prospective, randomized, double-blind… (More)
Is this relevant?
2000
2000
BACKGROUND Lacidipine is a widely used calcium-channel blocker, which has both long-lasting antihypertensive activity and also… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND The possibility that calcium antagonists exert an anti-atherosclerotic action at least partly independently of the… (More)
Is this relevant?
1997
1997
Essential hypertension is characterized by impaired endothelium-dependent vasodilation. The present study was designed to test… (More)
Is this relevant?
1992
1992
Lacidipine, a new, long-acting antihypertensive dihydropyridine calcium antagonist was tested for potential antioxidant effect in… (More)
Is this relevant?